Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates

FEMS Immunology and Medical Microbiology

Volumn 41, Issue 2, 2004, Pages 109-115

  Hu, Wei Gang ^a,b   Berry, Julie ^a   Chen, Jing ^a   Gu, Xin Xing ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

Author keywords

Carrier; CD; Conjugate; LOS; Moraxella catarrhalis; UspA

Indexed keywords

DRUG CARRIER; LIPOOLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; PROTEIN CD; UBIQUITOUS SURFACE PROTEIN A; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CONJUGATE; CONTROLLED STUDY; DETOXIFICATION; DRUG CONJUGATION; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CARRIER PROTEINS; COLONY COUNT, MICROBIAL; FEMALE; IMMUNIZATION; IMMUNOCONJUGATES; IMMUNODIFFUSION; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; RANDOM ALLOCATION; VACCINES, CONJUGATE;

EID: 2442507111     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.02.001     Document Type: Article

References (43)

1. Bluestone C.D. Otitis media and sinusitis in children. Role of Branhamella catarrhalis. Drugs. 31:1986;132-141
2. Boyle F.M., Georghiou P.R., Tilse M.H., McCormack J.G. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med. J. Aust. 154:1991;592-596
3. Hager H., Verghese A., Alvarez S., Berk S.L. Branhamella catarrhalis respiratory infections. Rev. Infect. Dis. 9:1987;1140-1149
4. Nicotra B., Rivera M., Luman J.I., Wallace R.J. Jr. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch. Intern. Med. 146:1986;890-893
5. McMichael J.C. Progress toward the development of a vaccine to prevent Moraxella (Branhamella) catarrhalis infections. Microb. Infect. 2:2000;561-568
6. Doyle W.J. Animal models of otitis media: other pathogens. Pediatr. Infect. Dis. J. 8:1989;S45-S47
7. Fomsgaard J.S., Fomsgaard A., Hoiby N., Bruun B., Galanos C. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect. Immun. 59:1991;3346-3349
8. Hu W.G., Chen J., McMicahel J.C., Gu X.X. Functional characteristics of a protective monoclonal antibody to lipooligosaccharide from Moraxella catarrhalis. Infect. Immun. 69:2001;1358-1363
9. Hu W.G., Chen J., Battey J.F., Gu X.X. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins. Infect. Immun. 68:2000;4980-4985
10. Peltola H., Kayhty H., Sivonen A., Makela H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100, 000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 60:1977;730-737
11. Koskela M., Leinonen M., Haiva V.M., Timonen M., Makela P.H. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr. Infect. Dis. 5:1985;45-50
12. Robbins J.B., Schneerson R. Polysaccharide-protein conjugates: a new generation of vaccines. J. Infect. Dis. 161:1990;821-832
13. Donnelly J.J., Liu M.A. Immunobiology of protein carriers. Ellis R.W., Granoff D.M. Development and Clinical Uses of Haemophilus b Conjugate Vaccines. 1994;71-90 Marcel Dekker, New York
14. Gu X.X., Chen J., Barenkamp S.J., Robbins J.B., Tsai C.M., Lim D.J., Battey J. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect. Immun. 66:1998;1891-1897
15. Herzenberg L.A., Tokuhisa T., Herzenberg L.A. Carrier-priming leads to hapten-specific suppression. Nature. 285:1980;664-667
16. Sad S., Gupta H.M., Talwar G.P., Raghupathy R. Carrier-induced suppression of the antibody response to a 'self' hapten. Immunology. 74:1991;223-227
17. Kaliyaperumal A., Chauhan V.S., Talwar G.P., Raghupathy R. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate. Eur. J. Immunol. 25:1995;3375-3380
18. Gaur A., Arunan K., Singh O., Talwar G.P. Bypass by an alternate 'carrier' of acquired unresponsiveness to hCG upon repeated immunization with tetanus-conjugated vaccine. Int. Immunol. 2:1990;151-155
19. Barington T., Skettrup M., Juul L., Heilmann C. Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components. Infect. Immun. 61:1993;432-438
20. Barington T., Gyhrs A., Kristensen K., Heilmann C. Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect. Immun. 62:1994;9-14
21. Yang Y.P., Myers L.E., McGuinness U., Chong P., Kwok Y., Klein M.H., Harkness R.E. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies. FEMS Immunol. Med. Microbiol. 17:1997;187-199
22. Murphy T.F., Kirkham C., Lesse A.J. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol. Microbiol. 10:1993;87-97
23. Helminen M.E., Maciver I., Latimer J.L., Klesney-Tait J., Cope L.D., Paris M., McCracken G.H. Jr., Hansen E.J. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:1994;867-872
24. Klingman K.L., Murphy T.F. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect. Immun. 62:1994;1150-1155
25. Chen D., McMichael J.C., VanDerMeid K.R., Hahn D., Mininni T., Cowell J., Eldridge J. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect. Immun. 64:1996;1900-1905
26. Gu X.X., Tsai C.M. Purification of rough-type lipopolysaccharides of Neisseria meningitidis from cells and outer membrane vesicles in spent media. Anal. Biochem. 196:1991;311-318
27. Chen D., Barniak V., VanDerMeid K.R., McMichael J.C. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect. Immun. 67:1999;1310-1316
28. McMichael J.C., Fiske M.J., Fredenburg R.A., Chakravarti D.N., VanDerMeid K.R., Barniak V., Caplan J., Bortell E., Baker S., Arumugham R., Chen D. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect. Immun. 66:1998;4374-4381
29. Neville D.M., Scharff J., Srinivasachar K. In vivo T-cell ablation by a holo-immunotoxin directed at human CD3. Proc. Natl. Acad. Sci. USA. 89:1992;2585-2589
30. Dubois M., Gillis H., Hamilton J.K., Rebers A.A., Smith R. Colorimetric method for the determination of sugars and related substances. Anal. Biochem. 28:1956;250-256
31. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85
32. Barenkamp S.J., Leininger E. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 60:1992;1302-1313
33. Gu X.X., Tsai C.M., Ueyama T., Barenkamp S.J., Robbins J.B., Lim D.J. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect. Immun. 64:1996;4047-4053
34. Hu W.G., Chen J., Collins F.M., Gu X.X. An aerosol challenge mouse model for Moraxella catarrhalis. Vaccine. 18:1999;799-804
35. Panpitpat C., Thisyakorn U., Chotpitayasunondh T., Furer E., Que J.U., Hasler T., Cryz S.J. Jr. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Bull. World Health Organ. 78:2000;364-371
36. Shah S., Raghupathy R., Singh O., Talwar G.P., Sodhi A. Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine. Vaccine. 17:1999;3116-3123
37. Herzenberg L.A., Tokuhisa T., Hayakawa K. Epitope-specific regulation. Annu. Rev. Immunol. 1:1983;609-632
38. Schutze M.P., Deriaud E., Przewlocki G., LeClerc C. Carrier-induced epitopic suppression is initiated through clonal dominance. J. Immunol. 142:1989;2635-2640
39. Zollinger W.D., Moran E.E., Devi S.J., Frasch C.E. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines. Infect. Immun. 65:1997;1053-1060
40. Harrison L.H., Tajkowski C., Croll J., Reid R., Hu D., Brenneman G., Weatherholtz R.C., Santosham M. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitides outer-membrane protein complex conjugate vaccine among Navajo children. J. Pediatr. 125:1994;571-576
41. Gravekamp C., Kasper D.L., Paoletti L.C., Madoff L.C. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. Infect. Immun. 67:1999;2491-2496
42. Wu T.H., Gu X.X. Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae. Infect. Immun. 67:1999;5508-5513
43. Anderson P.W., Pichichero M.E., Stein E.C., Porcelli S., Betts R.F., Connuck D.M., Korones D., Insel R.A., Zahradnik J.M., Eby R. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197. J. Immunol. 142:1989;2464-2468